Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioceres Crop Solutions (BIOX) Operating Leases (2019 - 2025)

Bioceres Crop Solutions' Operating Leases history spans 3 years, with the latest figure at $9.5 million for Q2 2025.

  • For Q2 2025, Operating Leases changed N/A year-over-year to $9.5 million; the TTM value through Jun 2025 reached $9.5 million, changed N/A, while the annual FY2025 figure was $9.5 million, N/A changed from the prior year.
  • Operating Leases for Q2 2025 was $9.5 million at Bioceres Crop Solutions, down from $10.3 million in the prior quarter.
  • Across five years, Operating Leases topped out at $10.3 million in Q2 2022 and bottomed at $390409.0 in Q2 2021.
  • The 3-year median for Operating Leases is $9.5 million (2025), against an average of $6.8 million.
  • The largest YoY upside for Operating Leases was 2548.09% in 2022 against a maximum downside of 2548.09% in 2022.
  • A 3-year view of Operating Leases shows it stood at $390409.0 in 2021, then surged by 2548.09% to $10.3 million in 2022, then decreased by 7.84% to $9.5 million in 2025.
  • Per Business Quant, the three most recent readings for BIOX's Operating Leases are $9.5 million (Q2 2025), $10.3 million (Q2 2022), and $390409.0 (Q2 2021).